Lexaria Bioscience Corp.
|
|||
| Mailing Address: | 100 - 740 McCurdy Road Kelowna, British Columbia V1X 2P7 |
Head Office Address: | 100 - 740 McCurdy Road Kelowna, British Columbia V1X 2P7 |
| Contact Name: | Chris Bunka | Principal Regulator: | British Columbia |
| Business e-mail address: | IR@LexariaBioscience.com | Short Form Prospectus Issuer: | Yes |
| Telephone Number: | 250 765-6424 | Reporting Jurisdictions: | British Columbia, Ontario, Other than Canada |
| Fax Number: | Stock Exchange: | NASDAQ | |
| Date of Formation: | Dec 9 2004 | Stock Symbol: | LEXX |
| Jurisdiction Where Formed: | Nevada | Auditor: | Davidson & Company LLP |
| Industry Classification: | consumer products - biotechnology/pharmaceuticals | General Partner: | |
| CUSIP Number: | 52886N | Transfer Agent: | Computershare Trust Company of Canada |
| Financial Year-End: | Aug 31 | Size of Issuer (Assets): | Under $5,000,000 |
|
